Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$820M |
| 2 |
Palo Alto Networks
PANW
|
+$358M |
| 3 |
Visa
V
|
+$355M |
| 4 |
CELG
Celgene Corp
CELG
|
+$339M |
| 5 |
Citigroup
C
|
+$325M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$722M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$356M |
| 3 |
Alibaba
BABA
|
+$345M |
| 4 |
EOG Resources
EOG
|
+$344M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.08% |
| 2 | Consumer Discretionary | 17.25% |
| 3 | Communication Services | 14.3% |
| 4 | Technology | 13.13% |
| 5 | Financials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Expedia Group
EXPE
$36.5B
| $687K | ﹤0.01% |
5,842
-3,000
| -34% | -$346K |
|
652
Verizon
VZ
$197B
| $677K | ﹤0.01% |
15,567
-7,912
| -34% | -$365K |
|
653
Outfront Media
OUT
$5.75B
| $646K | ﹤0.01% |
31,539
+1,866
| +6% | +$43.8K |
|
654
Verastem
VSTM
$528M
| $638K | ﹤0.01% |
29,720
-8,075
| -21% | -$639K |
|
|
HCC
655
DELISTED
HCC INSURANCES HOLDINGS INC
HCC
| $631K | ﹤0.01% |
+8,149
| New | +$630K |
|
|
HF
656
DELISTED
HFF Inc.
HF
| $622K | ﹤0.01% |
18,411
-44,507
| -71% | -$1.76M |
|
|
STJ
657
DELISTED
St Jude Medical
STJ
| $617K | ﹤0.01% |
+9,774
| New | +$698K |
|
|
INFN
658
DELISTED
Infinera Corporation Common Stock
INFN
| $607K | ﹤0.01% |
31,057
-86,473
| -74% | -$1.88M |
|
|
PPLI
659
People Inc
PPLI
$3.12B
| $576K | ﹤0.01% |
+49,402
| New | +$656K |
|
660
Euronet Worldwide
EEFT
$3.19B
| $575K | ﹤0.01% |
7,767
-16,015
| -67% | -$1.07M |
|
661
Huron Consulting
HURN
$2.71B
| $560K | ﹤0.01% |
8,960
-35,006
| -80% | -$2.51M |
|
662
Insperity
NSP
$2.03B
| $552K | ﹤0.01% |
25,152
-9,022
| -26% | -$214K |
|
663
Invesco
IVZ
$12.4B
| $520K | ﹤0.01% |
16,662
-18,208
| -52% | -$648K |
|
664
Zumiez
ZUMZ
$330M
| $519K | ﹤0.01% |
33,210
-22,962
| -41% | -$524K |
|
665
Omnicell
OMCL
$1.88B
| $510K | ﹤0.01% |
16,383
-77
| -0.5% | -$2.76K |
|
666
Graco
GGG
$13.2B
| $508K | ﹤0.01% |
+22,743
| New | +$524K |
|
|
IMPV
667
DELISTED
Imperva, Inc.
IMPV
| $506K | ﹤0.01% |
7,733
+207
| +3% | +$13.7K |
|
668
Raymond James Financial
RJF
$33.5B
| $491K | ﹤0.01% |
14,838
+5,574
| +60% | +$207K |
|
669
Intel
INTC
$413B
| $479K | ﹤0.01% |
15,896
-92,058
| -85% | -$2.66M |
|
|
LMOS
670
DELISTED
Lumos Networks Corp
LMOS
| $474K | ﹤0.01% |
38,999
-47,682
| -55% | -$622K |
|
671
Ameris Bancorp
ABCB
$5.89B
| $473K | ﹤0.01% |
16,463
-26,030
| -61% | -$707K |
|
672
Crane NXT
CXT
$2.99B
| $469K | ﹤0.01% |
28,971
-1,883
| -6% | -$34.6K |
|
|
TVTY
673
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $461K | ﹤0.01% |
41,482
-119,783
| -74% | -$1.46M |
|
674
Glacier Bancorp
GBCI
$6.36B
| $448K | ﹤0.01% |
16,960
-81,270
| -83% | -$2.24M |
|
675
AGCO
AGCO
$8.41B
| $433K | ﹤0.01% |
9,278
+1,208
| +15% | +$61.9K |
|
Similar funds
Jennison Associates's Q3 2015 Portfolio in Review
As of Q3 2015, Jennison Associates held 813 positions worth $97.6B, down 11% from $109B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jennison Associates's Q3 2015 filing shows 84 new, 272 increased, 353 reduced and 92 closed positions. Its largest new stake was Palo Alto Networks: 12,124,434 shares worth $348M. The largest sale was Gilead Sciences, an estimated $722M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q3 2015 buy was Palo Alto Networks: 12,124,434 shares worth $348M.
- Jennison Associates added most to Alphabet (Google) Class C in Q3 2015, an estimated $820M increase.
- Jennison Associates's biggest Q3 2015 reduction was Gilead Sciences, cutting an estimated $722M.
- Jennison Associates fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $144M.
- Jennison Associates's ten largest holdings make up 24% of its $97.6B portfolio in Q3 2015.
- Jennison Associates opened 84 new positions and closed 92 in Q3 2015.
- Jennison Associates's portfolio value fell 11% quarter-over-quarter to $97.6B.
Based on Jennison Associates's 13F filing for Q3 2015, filed 6 Nov 2015.